Michael David Vogtman, LGPC, CRC | |
650 Pennsylvania Ave Se Ste 440, Washington, DC 20003-4424 | |
(443) 275-8553 | |
Not Available |
Full Name | Michael David Vogtman |
---|---|
Gender | Male |
Speciality | Counselor |
Location | 650 Pennsylvania Ave Se Ste 440, Washington, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083366538 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michael David Vogtman, LGPC, CRC 650 Pennsylvania Ave Se Ste 440, Washington, DC 20003-4424 Ph: (443) 275-8553 | Michael David Vogtman, LGPC, CRC 650 Pennsylvania Ave Se Ste 440, Washington, DC 20003-4424 Ph: (443) 275-8553 |
News Archive
Gov. Mark Dayton and lawmakers reached agreement on a new set of budget bills ... State spending for health and human services will be up from about $10.2 billion this biennium but well below the $12.3 billion projected under current law.
Very small differences in the way a patient lies during radiotherapy treatment for lung or oesophageal cancer can have an impact on how likely they are to survive, according to research presented at the ESTRO 37 conference.
DiaTech Oncology announced today they have engaged in a pilot with Walter Reed Army Medical Center to determine the best Chemotherapy for Cancer patients. Medical and GYN Oncologists and from Walter Reed have been working with DiaTech Oncology (Nashville, TN) using the MiCK assay for apoptosis in order to give physicians a tool that can predict the best chemotherapy pathway in treating cancer patients.
In the 1950s and 1960s, pregnant women with morning sickness were often prescribed the new drug thalidomide. Shortly after the medicine was released on the market, a reported 10,000 infants were born with an extreme form of the rare congenital phocomelia syndrome, which caused death in 50 percent of cases and severe physical and mental disabilities in others.
A new technology developed at the University of Toronto is revealing biochemical processes responsible for diseases such as cystic fibrosis and could one day pave the way for pharmaceutical applications.
› Verified 5 days ago
Ms. Cassaundra Janiece Wilkins, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3861 Alabama Ave Se, Washington, DC 20020 Phone: 202-645-4488 Fax: 202-645-4590 | |
Ms. Pauline Imbrigato, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1012 14th St Nw, Suite 1025, Washington, DC 20005 Phone: 202-737-6000 Fax: 202-737-2332 | |
Giovanna Ysabela Dilauro, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1110 Lamont St Nw, Washington, DC 20010 Phone: 407-731-4581 | |
Joseph Martinez-williams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Q St Ne, Washington, DC 20002 Phone: 202-674-2256 | |
Elyse Figueroa, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2812 Erie St Se Apt B34, Washington, DC 20020 Phone: 646-744-4458 | |
Melissa Cimino, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 915 Rhode Island Ave Nw, Washington, DC 20001 Phone: 202-232-6810 | |
Lili Johnson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 441 21st St Ne, Washington, DC 20002 Phone: 202-341-6761 |